Sanofi, Axa, Aviva, Pro BTP and CNP Assurances were among the backers of the vehicle, which will focus on biotech investments.
France-based, biotech-focused private equity firm Jeito Capital has closed its Jeito I fund, which is backed by pharmaceutical company Sanofi and insurers Axa, Aviva, Pro BTP and CNP Assurances, at $632m.
The latest batch of limited partners for the fund include pension fund Teacher Retirement System of Texas (TRS), the Singaporean government-owned Temasek and the multilateral European Investment Fund (EIF).
Jeito I, the firm’s inaugural fund, surpassed its $586m target and will invest in biotech and biopharmaceutical companies specialising in…
Fernando Moncada Rivera
Fernando Moncada Rivera is a reporter at Global Corporate Venturing and also host of the CVC Unplugged podcast.
